1 / 12

Apheresis Red Cell Technology

Apheresis Red Cell Technology. Strategy for Increasing the Blood Supply. Units of Group O positive blood listed as available versus requested by Blood Centers . 20,000. 18,000. 16,000. 14,000. 12,000. 10,000. 8,000. 6,000. 4,000. 2,000. National Blood Exchange - Supply and Demand.

uttara
Download Presentation

Apheresis Red Cell Technology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Apheresis Red Cell Technology Strategy for Increasing the Blood Supply

  2. Units of Group O positive blood listed as available versus requested by Blood Centers 20,000 18,000 16,000 14,000 12,000 10,000 8,000 6,000 4,000 2,000 National Blood Exchange - Supply and Demand Units requested Units listed Winter Fall 25,000 20,000 15,000 Number of Units 10,000 5,000 1990-91 1994-95 1991-92 1992-93 1993-94 1995-96 1996-97 1997-98 1989-90 1989-90 1991-92 1992-93 1993-94 1994-95 1995-96 1996-97 1997-98 1990-91 Year Year Source: AABB News, March 1999

  3. U.S. Blood Donation DeclineNational Blood Data Resource Center • Blood Supply ,Transfusions  • By year 2000 the blood supply will  by 600,000 units. • This is 249,000 units < expected need • Blood supply trend: • Units Transfused1992 - 11.3 million transfusion1997 - 11.5 million transfusions • Units Collected • 1992 - 13.2 million donations • 1994 - 12.9 million donations • 1997 - 12.3 million donations

  4. Red Cell Apheresis Protocols • Two-Units of Red Cells • Red Blood Cells and Plasma • From 1 donation

  5. Apheresis Red Cell FDA Clearance History April 1998 First 2-RBC Blood Bank License 1997 510(k) clearance for Allogeneic 2-RBC 1996 510(k) clearance for Autologous 2-RBC 1995 510(k) clearance for Allogeneic / Autologous RBC & Plasma

  6. 2RBC Allogeneic Nomogram • Males • 130 pounds • 5’1” height • 40% hematocrit • 112 day deferral • Females • 150 pounds • 5’5” height • 40% hematocrit • 112 day deferral RBCP nomogram is the same as whole blood.

  7. Worldwide Apheresis Red Cell Growth * Actual data annualized.

  8. 2RBC Conversion Strategy: Group O & B Donors 962,000 more RBC Products (Early) (8%) 1,620,000 more RBC Products (Mature)(14%) Assumption: 12 Million WB Donations. 70% Mobile.

  9. Face-to-Face Conversion Success • Whole Blood to Apheresis Collection through face-to-face conversion. • No telerecruitment used • Approximately 50% increase in 2RBC procedures from April to June • Approximately 21% increase in RBCP procedures from April to June Procedures

  10. Apheresis Red Cell Leukoreduction • Europe in-line leukoreduction since 1996. • Domestic 2RBC in-line leukoreduction in clinical trials.

  11. Economics • Recently Haemonetics and an economics consulting firm collected data from 15 blood centers across the United States pertaining to whole blood collections. • Study conclusion of 15 Blood Centers: clear cut advantage in replacing certain whole blood collections.

  12. Conclusion Apheresis Red Cell Technology

More Related